← Leaderboards
Min Gyu Lee
University Of Tx Md Anderson Can Ctr
$8,063,863
Attributed
$8,063,863
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $772.3K · FY2011–25$1M$750K$500K$250K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,063,863 · 5
By mechanism
R01$8,063,863 · 5
Top collaborators
No co-investigators on record.
Most similar at University Of Tx Md Anderson Can Ctr
Same institution · by research overlap
- Taiping Chen$5,535,689
- Margarida Santos$1,372,502
Others in their field
Top investigators on “Mediating”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Lawrence Corey · Fred Hutchinson Cancer Center$493,822,581
- Barton F Haynes · Duke University$295,802,493
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$286,700,869
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$176,977,598
- Dan H. Barouch · Fred Hutchinson Cancer Center$122,734,499
Research focus
MediatingEpigenetic ProcessInsightGene Expression RegulationMolecularHistonesLysineGenesHistone H3MethylationTumor Suppressor GenesMouse ModelIn VivoBaseMutationGene ExpressionSignal TransductionTranscriptional RegulationGenome-WideChromatinCellsEpigenetic RegulationChip-SeqGenetic Transcription
Grant awards (23)
Heterozygous KMT2D Loss and Medulloblastoma$440,392
R01 · FY2025 · CA · contact PI
Heterozygous KMT2D Loss and Medulloblastoma$418,372
R01 · FY2024 · CA · contact PI
Heterozygous KMT2D Loss and Medulloblastoma$431,585
R01 · FY2023 · CA · contact PI
Heterozygous KMT2D Loss and Medulloblastoma$440,392
R01 · FY2022 · CA · contact PI
Role of the Histone Methyltransferase MLL4 in Medulloblastoma$366,341
R01 · FY2021 · CA · contact PI
Role of the Histone Modifier KDM2A in Lung Cancer$366,000
R01 · FY2021 · CA · contact PI
Role of the Histone Methyltransferase MLL4 in Medulloblastoma$366,341
R01 · FY2020 · CA · contact PI
Role of the Histone Modifier KDM2A in Lung Cancer$366,000
R01 · FY2020 · CA · contact PI
Role of the Histone Methyltransferase MLL4 in Medulloblastoma$355,350
R01 · FY2019 · CA · contact PI
Role of the Histone Modifier KDM2A in Lung Cancer$355,019
R01 · FY2019 · CA · contact PI
Role of the Histone Methyltransferase MLL4 in Medulloblastoma$406,341
R01 · FY2018 · CA · contact PI
Role of the Histone Modifier KDM2A in Lung Cancer$366,000
R01 · FY2018 · CA · contact PI
Role of the Histone Methyltransferase MLL4 in Medulloblastoma$381,114
R01 · FY2017 · CA · contact PI
Role of the Histone Modifier KDM2A in Lung Cancer$366,000
R01 · FY2017 · CA · contact PI
Role of the Histone demethylase JARID1d in Epigenetic Events of Prostate Cancer$296,250
R01 · FY2015 · CA · contact PI
Role of the Histone Modifier KDM6A in Stem Cell Differentiation$298,620
R01 · FY2014 · GM · contact PI
Role of the Histone demethylase JARID1d in Epigenetic Events of Prostate Cancer$287,363
R01 · FY2014 · CA · contact PI
Role of the Histone Modifier KDM6A in Stem Cell Differentiation$288,168
R01 · FY2013 · GM · contact PI
Role of the Histone demethylase JARID1d in Epigenetic Events of Prostate Cancer$278,475
R01 · FY2013 · CA · contact PI
Role of the Histone Modifier KDM6A in Stem Cell Differentiation$298,620
R01 · FY2012 · GM · contact PI
Role of the Histone demethylase JARID1d in Epigenetic Events of Prostate Cancer$296,250
R01 · FY2012 · CA · contact PI
Role of the Histone Modifier KDM6A in Stem Cell Differentiation$298,620
R01 · FY2011 · GM · contact PI
Role of the Histone demethylase JARID1d in Epigenetic Events of Prostate Cancer$296,250
R01 · FY2011 · CA · contact PI